Evidence map›Paper›PMID 15309560›Full record

ReviewChromosoma2004

MRE11/RAD50/NBS1: complex activities.

Nora Assenmacher, Karl-Peter Hopfner

Abstract readReview
PubMed Publisher
In one paragraph

Review in Chromosoma, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 152 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Plasticity of theF1000Research · 2016
    Review
  13. Heterozygous p.I171V mutation of theOncology letters · 2015
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nora AssenmacherGene Center, University of Munich, Feodor-Lynen-Str. 25, 81377 Munich, Germany.
Karl-Peter Hopfner
Technical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The MRE11/RAD50/NBS1 complex (Mre11 complex) is a central player in most aspects of the cellular response to DNA double-strand breaks, including homologous recombination, non-homologous end joining, telomere maintenance and DNA damage checkpoint activation. Several of these findings are explained by the unusual enzymatic activities and macromolecular structure of the Mre11 complex. The Mre11 complex possesses an ATP-stimulated nuclease to process heterogeneous DNA ends and long coiled-coil tails to link DNA ends and/or sister chromatids. However, the mechanistic role of the Mre11 complex in checkpoint activation has been unclear until recently. New data suggest that the Mre11 complex can directly activate the ATM checkpoint kinase at DNA breaks. These findings, together with newly determined functional interactions, identify the Mre11 complex as an architectural and mechanistic keystone of cellular response events emerging from DNA breaks.

Indexed as

Chromosome BreakageAcid Anhydride HydrolasesAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsDeoxyribonucleasesDNA-Binding ProteinsDNA HelicasesDNA Repair EnzymesDNA ReplicationHumansMRE11 Homologue ProteinNuclear ProteinsProtein Serine-Threonine KinasesTumor Suppressor ProteinsAcid Anhydride HydrolasesAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsDeoxyribonucleasesDNA-Binding ProteinsDNA HelicasesDNA Repair EnzymesMRE11 Homologue ProteinMRE11 protein, humanNBN protein, humanNuclear ProteinsProtein Serine-Threonine KinasesRAD50 protein, humanTumor Suppressor Proteins

Identifiers

PMID15309560
OpenAlexW2083331793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.